Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYAntioxidants (Basel, Switzerland)

Myricitrin Delays Caenorhabditis elegans Aging: Association with DAF-16, SIR-2.1, and Potential Cholinergic Modulation.

  1. 1School of Life Sciences, Sichuan Normal University, Chengdu 610101, China.

Abstract

Background

Aging involves progressive functional decline driven by oxidative stress and mitochondrial dysfunction, and dietary flavonoids are promising aging interventions due to their multi-target regulatory pathways.Methods

This study systematically evaluated the anti-aging activity of myricitrin (MYR) and its underlying mechanisms using Caenorhabditis elegans, testing MYR at 0.25 mg/mL, employing a rotenone-induced model of mitochondrial oxidative stress, and performing reporter strain analyses, qRT-PCR, and molecular docking analysis with acetylcholinesterases (ACE-1/2).Results

MYR at 0.25 mg/mL significantly extended lifespan and improved locomotor performance without detectable toxicity regarding growth, feeding, or reproduction; reduced reactive oxygen species accumulation and restored antioxidant enzyme activities in the rotenone-induced model; was accompanied by the nuclear translocation of DAF-16 and the upregulation of associated downstream antioxidant genes (sod-3, gst-4); enhanced mitochondrial quality control by upregulating sir-2.1 and modulating genes associated with the mitochondrial unfolded protein response (atfs-1, hsp-6) and mitochondrial dynamics (fzo-1, drp-1); and indicated a favorable interaction between MYR and acetylcholinesterases (ACE-1/2).Conclusions

MYR represents a promising candidate compound for mitigating aging-related phenotypes, with its beneficial effects linked to a DAF-16-associated antioxidant response and SIR-2.1-correlated mitochondrial quality control network.

Related

  1. Cholinergic and adrenergic modulation sculpts parallel inhibition of SST-INs in visual cortex
    J. Gupta, C. Chiu, F. Veneto +2
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxivPMC
  2. Effort experience as a driver of behavioral modulation in Caenorhabditis elegans
    R. Arbid, I. Rabinowitch
    bioRxivPreprintCC BY-NC-NDFull textNeurosciencebioRxiv
  3. Cholinergic Modulation of Proteinoid Microsphere Networks as Prebiotic Depression Models
    Panagiotis Mougkogiannis, Andrew Adamatzky
    ACS Physical Chemistry AuPeer-reviewedCC BY5 citedNeuroscienceOpenAlex
  4. A semi-automated genetic screen using genome-wide association analysis identifies modulators of stress-induced sleep in Caenorhabditis elegans
    Zihao (John) Li, Helya Honarpisheh, Sreekar Kutagulla +4
    G3: Genes | Genomes | GeneticsPeer-reviewedCC BY 4.0Full textNeurosciencePMC
  5. Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities
    Swaraj Kumar Babu, Sk Mustaq Ali, Dibya Ranjan Sahoo +5
    3 BiotechPeer-reviewedLicence not statedFull textPlant biologyPMC
BibTeX
@article{yang2026myricitrin,
  title = {{Myricitrin Delays Caenorhabditis elegans Aging: Association with DAF-16, SIR-2.1, and Potential Cholinergic Modulation.}},
  author = {Lijun Yang and Jiuyi Li and Yihan Zhou and Huaying Xu and Yu Wang and Jiayuan Zhao and Yanan Wang},
  journal = {Antioxidants (Basel, Switzerland)},
  year = {2026},
  month = sep,
  doi = {10.3390/antiox15101230},
  url = {https://europepmc.org/article/MED/42939805},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Myricitrin Delays Caenorhabditis elegans Aging: Association with DAF-16, SIR-2.1, and Potential Cholinergic Modulation.
AU  - Lijun Yang
AU  - Jiuyi Li
AU  - Yihan Zhou
AU  - Huaying Xu
AU  - Yu Wang
AU  - Jiayuan Zhao
AU  - Yanan Wang
PY  - 2026
DA  - 2026/09/23
JO  - Antioxidants (Basel, Switzerland)
DO  - 10.3390/antiox15101230
UR  - https://europepmc.org/article/MED/42939805
AB  - Background  Aging involves progressive functional decline driven by oxidative stress and mitochondrial dysfunction, and dietary flavonoids are promising aging interventions due to their multi-target regulatory pathways.Methods  This study systematically evaluated the anti-aging activity of myricitrin (MYR) and its underlying mechanisms using Caenorhabditis elegans, testing MYR at 0.25 mg/mL, employing a rotenone-induced model of mitochondrial oxidative stress, and performing reporter strain analyses, qRT-PCR, and molecular docking analysis with acetylcholinesterases (ACE-1/2).Results  MYR at 0.25 mg/mL significantly extended lifespan and improved locomotor performance without detectable toxicity regarding growth, feeding, or reproduction; reduced reactive oxygen species accumulation and restored antioxidant enzyme activities in the rotenone-induced model; was accompanied by the nuclear translocation of DAF-16 and the upregulation of associated downstream antioxidant genes (sod-3, gst-4); enhanced mitochondrial quality control by upregulating sir-2.1 and modulating genes associated with the mitochondrial unfolded protein response (atfs-1, hsp-6) and mitochondrial dynamics (fzo-1, drp-1); and indicated a favorable interaction between MYR and acetylcholinesterases (ACE-1/2).Conclusions  MYR represents a promising candidate compound for mitigating aging-related phenotypes, with its beneficial effects linked to a DAF-16-associated antioxidant response and SIR-2.1-correlated mitochondrial quality control network.
SN  - 2076-3921
ER  -